• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON & CO. (SPARKS) BD BBL MGIT MYCOBACTERIA GROWTH INDICATOR TUBES, 7ML; SYSTEM, BLOOD CULTURING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON & CO. (SPARKS) BD BBL MGIT MYCOBACTERIA GROWTH INDICATOR TUBES, 7ML; SYSTEM, BLOOD CULTURING Back to Search Results
Model Number 245122
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problems No Patient Involvement (2645); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/20/2021
Event Type  malfunction  
Manufacturer Narrative
A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.(b)(4).
 
Event Description
It was reported that prior to use with bd bbl¿ mgit¿ mycobacteria growth indicator tubes, 7ml growth without sample inoculation was discovered in tube.
 
Manufacturer Narrative
H.6.Investigation: this product is manufactured by rehydrating the media components with usp purified water, and thoroughly mixing until a homogeneous solution is obtained.The tubes are filled, capped, torqued and then labeled by machine per standard operating procedure (sop).The tubes are terminally autoclaved in an air over pressure (aop) autoclave, per manufacturing instructions, using a validated cycle.Post autoclaving, tubes are packaged into final shipping configurations.The batch history record review for batch 0231573 was satisfactory and a quality notification were generated during manufacturing and inspection.Formulation, filling, and torqueing processes were within specifications.In process checks were performed during manufacturing at designated intervals per procedures.Qc inspection and testing were satisfactory at time of release.As part of the release criteria for this product, the bhr is reviewed to confirm the following: the total elapsed time between end of formulation and start of the autoclave cycle was within the specified limits.All autoclave parameters conformed to the validated cycle parameters for this product.The minimum f0 for this product was met.The complaint history was reviewed, and no other complaints have been taken on this batch.Retention samples from batch 0231573 (100 tubes) were available for inspection.The retention samples showed no cap, tube, or media defects in 100/100 tubes from visual inspection.Two photos were received in lieu of returns to assist with the investigation.The first photo shows a tube from batch 0231473.The second photo shows what appears to be a white circular particle.For investigation, a total of ten uninoculated retention tubes wen into incubation.Five tubes were placed in the 33 to 37 degrees celsius incubator and five tubes were placed in the 20 to 25 degrees celsius incubator.No microbial growth or turbidity of the media was seen in 10/10 incubated retention tubes at the end of the incubation period, and under uv light the incubated tubes did not show any increased fluorescence to indicate microbial growth.No microbial growth was observed in the retention samples.The complaint can be confirmed from the photos.
 
Event Description
It was reported that prior to use with bd bbl¿ mgit¿ mycobacteria growth indicator tubes, 7ml growth without sample inoculation was discovered in tube.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD BBL MGIT MYCOBACTERIA GROWTH INDICATOR TUBES, 7ML
Type of Device
SYSTEM, BLOOD CULTURING
Manufacturer (Section D)
BECTON, DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
MDR Report Key11301391
MDR Text Key230973576
Report Number1119779-2021-00276
Device Sequence Number1
Product Code MDB
UDI-Device Identifier30382902451229
UDI-Public30382902451229
Combination Product (y/n)N
PMA/PMN Number
K974883
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,other,user facility
Type of Report Initial,Followup
Report Date 06/25/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/09/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date02/16/2022
Device Model Number245122
Device Catalogue Number245122
Device Lot Number0231573
Was Device Available for Evaluation? No
Date Manufacturer Received06/25/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-